Clinical Evaluation of a Bioactive Material
Condition(s) studied
Investigational drug(s) / intervention(s)
bioactive composite: Cention N
posterior composite: G-ænial Posterior
Study summary
The clinical performance of a bioactive composite and a posterior resin composite in class II restorations will be evaluated and compared. After recruiting participants with at least 2 approximal caries lesions, all restorations will be placed by a single clinician. All caries lesions will be removed before restoring. Cavities will be divided into two groups: a bioactive composite \[Cention N, Ivoclar Vivadent, Schaan, Liechtenstein (CN)\] and a posterior resin composite \[G-ænial Posterior (GC, Tokyo, Japan) (GP)\] All restorative procedures will be conducted according to manufacturers' instructions. Restorations will be scored using FDI criteria after a week (baseline) 6, 12, 24, 36 and 48 months. Descriptive statistics will be performed using chi-square tests.
Eligibility
Primary outcome measure(s)
- Clinical performances of different restorative systems according to FDI criteria — two years
Two year results according to FDI criteria
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Hacettepe University | Ankara | Turkey (Türkiye) |
More Hacettepe University trials in Turkey
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT04825379 on ClinicalTrials.gov ↗ ← All trials in Turkey